|
|
Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort.
Stanislas Pol
,
Delphine Bonnet
,
Virginie Payssan-Sicart
,
Chloe Pomes
,
François Bailly
,
et al.
Journal articles
hal-03784807v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general population
Anne-Sophie Renard
,
Anita Paisant
,
Victoire Cartier
,
Paul Calès
,
Mirela Goyet-Prelipcean
,
et al.
Journal articles
hal-04048938v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
L’index FIB-4 pour faire le diagnostic de fibrose hépatique avancée au cours de la stéatose hépatique
Vincent Mallet
,
Lucia Parlati
,
Anaïs Vallet-Pichard
,
Benoit Terris
,
Emmanuel Tsochatzis
,
et al.
Journal articles
hal-03488833v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
[Editorial] Direct-Acting Antivirals and the Risk of Hepatocellular Carcinoma: The End of a Polemic?
Stanislas Pol
,
Anaïs Vallet-Pichard
,
Hélène Fontaine
,
Fabrice Carrat
Journal articles
hal-03777539v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective
Laurent Alric
,
Isabelle Ollivier-Hourmand
,
Emilie Berard
,
Sophie Hillaire
,
Maeva Guillaume
,
et al.
Journal articles
hal-01975350v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.
Armanda Casrouge
,
Jérémie Decalf
,
Mina Ahloulay
,
Cyril Lababidi
,
Hala Mansour
,
et al.
Journal articles
pasteur-01402089v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|